Abramson Cancer Center at the University of Pennsylvania /ID# 275407 — Philadelphia, Pennsylvania

Abramson Cancer Center at the University of Pennsylvania /ID# 275407 is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Clinical Trials Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.

Abramson Cancer Center at the University of Pennsylvania /ID# 275407 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Colorectal Cancer.

Sponsors: AbbVie.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Philadelphia

Browse all research sites in Pennsylvania · View every site in Philadelphia

Sponsor Feasibility Report

Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Abramson Cancer Center at the University of Pennsylvania /ID# 275407?

Abramson Cancer Center at the University of Pennsylvania /ID# 275407 has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Abramson Cancer Center at the University of Pennsylvania /ID# 275407 conducted?

Abramson Cancer Center at the University of Pennsylvania /ID# 275407 has 1 clinical trials on record, with 1 currently active. Their work covers Colorectal Cancer.

Is Abramson Cancer Center at the University of Pennsylvania /ID# 275407 accredited by Crixeo Clinical Trials?

Abramson Cancer Center at the University of Pennsylvania /ID# 275407 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Abramson Cancer Center at the University of Pennsylvania /ID# 275407?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.